• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺浸润性导管癌临床病理特征及生存结局的预后价值:一项基于人群的研究。

Prognostic values of clinicopathological characteristics and survival outcomes in prostate infiltrating ductal carcinoma: a population-based study.

作者信息

Wu Yu-Peng, Chen Shao-Hao, Wang Shi-Tao, Li Xiao-Dong, Cai Hai, Lin Yun-Zhi, Xue Xue-Yi, Wei Yong, Zheng Qing-Shui, Xu Ning

机构信息

Department of Urology, First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.

出版信息

Oncotarget. 2017 Apr 25;8(17):29048-29055. doi: 10.18632/oncotarget.16070.

DOI:10.18632/oncotarget.16070
PMID:28423709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5438711/
Abstract

Infiltrating ductal carcinoma (IDC) is a rare histologic subtype of prostate cancer. We investigated the clinicopathological features and prognosis of IDC compared with acinar cell carcinoma (ACC). We identified 3814 men diagnosed with prostate cancer between 2004 to and 2013 in the Surveillance, Epidemiology, and End Results database, including 511 IDC and 3303 ACC cases. Prostate cancer-specific survival (PCSS) was compared using univariate and multivariate Cox proportional hazards models. Generally, IDC occurred in older men (≥ 65 years old) and presented with larger sizes, and higher grades, American Joint Committee on Cancer (AJCC) stages, AJCC T stages, lymph node positive rates and metastasis rates. Men with IDC were less likely to undergo radical prostatectomy, but more likely to be treated with adjuvant radiation than men with ACC. Five-year PCSS rates were significantly worse in IDC. In the multivariate analysis, patients with ACC had a better PCSS than patients with IDC. In conclusion, IDC has unique clinicopathological characteristics and has worse prognosis than ACC. Multivariable Cox regression analysis showed that age over 85 years, higher grade and T stage, and metastasis at diagnosis were independent prognostic factors of worse survival outcomes, whereas radical prostatectomy was an independent prognostic factor of better survival outcomes.

摘要

浸润性导管癌(IDC)是前列腺癌中一种罕见的组织学亚型。我们研究了IDC与腺泡细胞癌(ACC)相比的临床病理特征和预后。我们在监测、流行病学和最终结果数据库中确定了2004年至2013年间被诊断为前列腺癌的3814名男性,其中包括511例IDC和3303例ACC病例。使用单变量和多变量Cox比例风险模型比较前列腺癌特异性生存率(PCSS)。一般来说,IDC发生在老年男性(≥65岁)中,肿瘤体积更大、分级更高、美国癌症联合委员会(AJCC)分期、AJCC T分期、淋巴结阳性率和转移率更高。与ACC患者相比,IDC患者接受根治性前列腺切除术的可能性较小,但接受辅助放疗的可能性更大。IDC患者的5年PCSS率明显更差。在多变量分析中,ACC患者的PCSS优于IDC患者。总之,IDC具有独特的临床病理特征,且预后比ACC更差。多变量Cox回归分析表明,85岁以上、更高的分级和T分期以及诊断时的转移是生存结果较差的独立预后因素,而根治性前列腺切除术是生存结果较好的独立预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3fe/5438711/ef072a01a918/oncotarget-08-29048-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3fe/5438711/776cf9db36b3/oncotarget-08-29048-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3fe/5438711/ef072a01a918/oncotarget-08-29048-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3fe/5438711/776cf9db36b3/oncotarget-08-29048-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3fe/5438711/ef072a01a918/oncotarget-08-29048-g002.jpg

相似文献

1
Prognostic values of clinicopathological characteristics and survival outcomes in prostate infiltrating ductal carcinoma: a population-based study.前列腺浸润性导管癌临床病理特征及生存结局的预后价值:一项基于人群的研究。
Oncotarget. 2017 Apr 25;8(17):29048-29055. doi: 10.18632/oncotarget.16070.
2
Contemporary Comparison of Clinicopathologic Characteristics and Survival Outcomes of Prostate Ductal Carcinoma and Acinar Adenocarcinoma: A Population-Based Study.基于人群的研究:前列腺导管腺癌和腺泡腺癌的临床病理特征和生存结局的当代比较。
Clin Genitourin Cancer. 2019 Jun;17(3):231-237.e2. doi: 10.1016/j.clgc.2019.04.009. Epub 2019 Apr 16.
3
Subgroups of parotid gland infiltrating ductal carcinoma benefit from postoperative radiotherapy: a population-based study.腮腺浸润性导管癌亚组受益于术后放疗:一项基于人群的研究。
Future Oncol. 2019 Mar;15(8):885-895. doi: 10.2217/fon-2018-0495. Epub 2019 Jan 22.
4
Population-based study of the incidence and survival for intraductal carcinoma of the prostate.基于人群的前列腺导管内癌发病率及生存率研究。
Urol Oncol. 2017 Dec;35(12):673.e9-673.e14. doi: 10.1016/j.urolonc.2017.08.015. Epub 2017 Sep 14.
5
The number and ratio of positive lymph nodes are independent prognostic factors for patients with major salivary gland cancer: Results from the surveillance, epidemiology, and End Results dataset.阳性淋巴结的数量和比例是大涎腺癌患者独立的预后因素:来自监测、流行病学和最终结果数据集的结果。
Eur J Surg Oncol. 2019 Jun;45(6):1025-1032. doi: 10.1016/j.ejso.2018.11.008. Epub 2018 Nov 15.
6
Similar outcomes between adenoid cystic carcinoma of the breast and invasive ductal carcinoma: a population-based study from the SEER 18 database.乳腺腺样囊性癌与浸润性导管癌的相似结局:一项基于SEER 18数据库的人群研究
Oncotarget. 2017 Jan 24;8(4):6206-6215. doi: 10.18632/oncotarget.14052.
7
Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions.前列腺导管内癌的异质性临床病理特征:“前体样”与“普通型”病变的比较
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2518-26. eCollection 2014.
8
Difference in characteristics and outcomes between medullary breast carcinoma and invasive ductal carcinoma: a population based study from SEER 18 database.髓样乳腺癌与浸润性导管癌的特征及预后差异:一项基于SEER 18数据库的人群研究
Oncotarget. 2016 Apr 19;7(16):22665-73. doi: 10.18632/oncotarget.8142.
9
Intraductal carcinoma of the prostate in prostate biopsy samples: correlation with aggressive pathological features after radical prostatectomy and prognostic value in high-risk prostate cancer.前列腺穿刺活检标本中的前列腺导管内癌:与根治性前列腺切除术后侵袭性病理特征的相关性及在高危前列腺癌中的预后价值。
Asian J Androl. 2020 Sep-Oct;22(5):519-525. doi: 10.4103/aja.aja_117_19.
10
Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study.被诊断患有转移性前列腺癌的男性是否会从原发性肿瘤的确定性治疗中获益?一项基于 SEER 的研究。
Eur Urol. 2014 Jun;65(6):1058-66. doi: 10.1016/j.eururo.2013.11.012. Epub 2013 Nov 20.

引用本文的文献

1
Solitary testicular metastasis post-prostatectomy for prostatic ductal adenocarcinoma: case report and literature review.前列腺导管腺癌前列腺切除术后孤立性睾丸转移:病例报告及文献复习
Front Oncol. 2025 Feb 27;15:1464446. doi: 10.3389/fonc.2025.1464446. eCollection 2025.
2
The Prognostic Value of the Prostate Adenocarcinoma With Ductal Feature in Patients With Advanced Prostate Cancer Treated With Abiraterone Acetate.醋酸阿比特龙治疗的晚期前列腺癌患者中具有导管特征的前列腺腺癌的预后价值
Prostate. 2025 May;85(7):659-669. doi: 10.1002/pros.24869. Epub 2025 Mar 4.
3
Nomogram for predicting the overall survival and cancer-specific survival of patients with intraductal carcinoma of the prostate.

本文引用的文献

1
Comparison of the efficacy and feasibility of en bloc transurethral resection of bladder tumor versus conventional transurethral resection of bladder tumor: A meta-analysis.整块经尿道膀胱肿瘤切除术与传统经尿道膀胱肿瘤切除术的疗效及可行性比较:一项荟萃分析。
Medicine (Baltimore). 2016 Nov;95(45):e5372. doi: 10.1097/MD.0000000000005372.
2
Management and therapeutic response of a prostate ductal adenocarcinoma: a still unknown tumour?前列腺导管腺癌的管理与治疗反应:一种仍不为人知的肿瘤?
Urologia. 2016 Sep 26;83(3):163-167. doi: 10.5301/uro.5000174. Epub 2016 May 6.
3
Clinicopathological Characteristics and Survival Outcomes of Invasive Cribriform Carcinoma of Breast: A SEER Population-Based Study.
列线图预测前列腺导管内癌患者的总生存和癌症特异性生存。
J Cancer Res Clin Oncol. 2024 Jan 28;150(2):45. doi: 10.1007/s00432-023-05582-5.
4
Ductal adenocarcinoma of the prostate: A systematic review and meta-analysis of incidence, presentation, prognosis, and management.前列腺导管腺癌:发病率、临床表现、预后及治疗的系统评价和荟萃分析
BJUI Compass. 2021 Jan 5;2(1):13-23. doi: 10.1002/bco2.60. eCollection 2021 Jan.
5
Are we progressing in prostate cancer management?我们在前列腺癌治疗方面取得进展了吗?
Asian J Urol. 2021 Apr;8(2):241-242. doi: 10.1016/j.ajur.2020.09.001. Epub 2020 Sep 11.
6
Oncological outcomes of patients with ductal adenocarcinoma of the prostate receiving radical prostatectomy or radiotherapy.接受根治性前列腺切除术或放射治疗的前列腺导管腺癌患者的肿瘤学结局。
Asian J Urol. 2021 Apr;8(2):227-234. doi: 10.1016/j.ajur.2020.05.005. Epub 2020 May 23.
7
Prostatic Ductal Adenocarcinoma Controlled for Cancer Grade and Tumor Volume Does Not Have an Independent Effect on Adverse Radical Prostatectomy Outcomes Compared to Usual Acinar Prostatic Adenocarcinoma.前列腺导管腺癌在控制肿瘤分级和肿瘤体积后,与常见的前列腺腺癌相比,对不利的根治性前列腺切除术结局没有独立影响。
Urology. 2020 Mar;137:108-114. doi: 10.1016/j.urology.2019.10.014. Epub 2019 Nov 9.
乳腺浸润性筛状癌的临床病理特征及生存结局:一项基于监测、流行病学和最终结果(SEER)数据库的人群研究
Medicine (Baltimore). 2015 Aug;94(31):e1309. doi: 10.1097/MD.0000000000001309.
4
Ductal and Acinar Adenocarcinoma of Prostate: Morphological and Immunohistochemical Characterization.前列腺导管腺癌和腺泡腺癌:形态学及免疫组化特征
Oman Med J. 2015 May;30(3):162-6. doi: 10.5001/omj.2015.36.
5
Clinicopathological features of prostate ductal carcinoma: matching analysis and comparison with prostate acinar carcinoma.前列腺导管癌的临床病理特征:匹配分析及与前列腺腺泡癌的比较
J Korean Med Sci. 2015 Apr;30(4):385-9. doi: 10.3346/jkms.2015.30.4.385. Epub 2015 Mar 19.
6
[Ductal carcinoma of the prostate: impact on survival and therapeutic controversies of a rare tumor].[前列腺导管癌:对一种罕见肿瘤生存率的影响及治疗争议]
Urologia. 2011 Oct-Dec;78(4):283-7. doi: 10.5301/RU.2011.8835.
7
Incidence and outcomes of ductal carcinoma of the prostate in the USA: analysis of data from the Surveillance, Epidemiology, and End Results program.美国前列腺导管癌的发病率和结局:监测、流行病学和最终结果计划的数据分析。
BJU Int. 2012 Mar;109(6):831-4. doi: 10.1111/j.1464-410X.2011.10520.x. Epub 2011 Aug 24.
8
Ductal adenocarcinoma of the prostate: increased mortality risk and decreased serum prostate specific antigen.前列腺导管腺癌:死亡率风险增加,前列腺特异性抗原降低。
J Urol. 2010 Dec;184(6):2303-7. doi: 10.1016/j.juro.2010.08.017. Epub 2010 Oct 16.
9
Prostatic adenocarcinoma of ductal origin.导管起源的前列腺腺癌。
Cancer. 1973 Aug;32(2):402-9. doi: 10.1002/1097-0142(197308)32:2<402::aid-cncr2820320218>3.0.co;2-q.
10
Adenocarcinoma of the prostate with endometrioid features. A light microscopic and immunohistochemical study of ten cases.具有子宫内膜样特征的前列腺腺癌。10例病例的光镜和免疫组化研究。
Cancer. 1986 Jan 1;57(1):111-9. doi: 10.1002/1097-0142(19860101)57:1<111::aid-cncr2820570123>3.0.co;2-n.